Breast Augmentation in ME
Breast Augmentation plastic surgery in ME section, includes general infrmation about Breast Augmentation Procedure, Breast Augmentation ME Local News, Breast Augmentation ME Surgeon Locator and other breast augmentation related materal.
ME Breast Augmentation - The Plastic Surgery Procedure
The plastic surgery operation is usually done when the breast reaches its final size after puberty (ages 17-18). Except for cases when there is congenital breast hypoplasia or breast asymmetry in which it can be done earlier (local regulations in ME may be applicable).
ME breast augmentation - the implants
There are three possible areas for the insertion of an implant for augmentation. The lower fold of the breast is the most common site. It allows full excess and lives a hidden scar. The second site is through the areola. This incision gives the best esthetic results but it is also the only one that goes through the breast tissue therefore the risk of infection and sensation loss is higher. The third one is through the armpits. Some plasit surgeons prefer it because the scar is almost invisible (except for those women who like to wear open close with no sleeves(. The disadvantage of this incision is a slight asymmetry of the breast. The decision usually made individually with each woman and the plastic surgeon (consult local ME surgeons).
The augmentation implant can be inserted above or below the chest muscles. The below position considered to be more preferable by most ME surgeons. There is less chance of feeling the implant, less chance of developing irregular folds or bumps on the surface of the breast and the implant is less likely to drop. This kind of plastic surgery technique is suitable for women with relatively little extra skin and less fallen breasts.
Most of the implants are made of silicon, and since the FDA determined that they safe for use they are being widely used by most plastic surgeons in ME.
[breast augmentation ME top]
ME breast augmentation - shape and size
The augmentation implants come in two shapes: round and pear shape also called "anatomic implants" because their shape resembles the natural contour of the breast. They are more expensive and require larger excision during the breast augmentation plastic surgery procedure.
The size of an implant usually depends on the woman size and proportions, the average size is 300cc. It is believed that smaller implants have lower complications.
[breast augmentation ME top]
ME breast augmentation - after the plastic surgery
After the augmentation plastic surgery you'll be wearing a sports bra or a bandage. You'll continue wearing them at all times day and night for about a month. You'll be able to take a shower 24 hours after the plastic surgery. The most optimal results usually seen 3 month after the surgery. Several things can complicate this plastic surgery procedure; those are rare complications, which you should be aware off. Bleeding around the area of the implant, infection, disturbances of sensation and touch around the nipples, silicon leak, rejection off an implant and some degree of irregularity on the surface of an implant.
Other Breast Augmentation Procedures
All Breast Plastic Surgery Procedures
ME Breast augmentation Plastic Surgery (current)
ME Breast Lift Plastic Surgery
ME Breast Implants Plastic Surgery
ME Implant Removal Plastic Surgery
ME Armpit Incision Plastic Surgery
More ME info...
Breast AugmentationLatest Forum Posts...
- Good morning to everyone!
I hope that this post isn’t “out” here. I would like just to say that if someone of you are thinking to have plastic surgery operations but they are very expensive, there’s something new for you:
Plastic Surgery News...
Objective To determine the efficacy of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris (PV).
Design A randomized, double-blind, placebo-controlled study with a crossover arm for those who failed treatment.
Setting A US multicenter outpatient study.
Patients A total of 19 subjects enrolled among 5 centers, 9 randomized to receive dapsone and 10 to receive placebo. Inclusion criteria were biopsy and direct immunofluorescence-proven PV controlled with glucocorticoids and/or cytotoxic agents, disease in maintenance phase, and aged 18 to 80 years. Physicians had tried at least 2 tapers of glucocorticoids unsuccessfully and had 30 days of stable steroid dosage. Treatment for any patient unable to taper glucocorticoids by more than 25% within 4 months was declared a failure, and the patient was allowed to switch to the opposite medication while maintaining the double-blind.
Main Outcome Measure The ability of patients to taper to 7.5 mg/d or less within 1 year of reaching the maximum dosage of the study drug.
Results Of the 9 patients receiving dapsone, 5 were successfully treated, 3 failed treatment, and 1 dropped out of the study. Of the 10 patients receiving placebo, 3 were successfully treated, and 7 failed treatment. This primary end point favored the dapsone-treated group but was not statistically significant (P = .37). Four patients who failed treatment while receiving placebo were switched to treatment with dapsone. Of these, 3 were successfully treated after switching to dapsone treatment, and 1 failed treatment. We found that, overall, 8 of 11 patients (73%) receiving dapsone vs 3 of 10 (30%) receiving placebo reached the primary outcome of a prednisone dosage of 7.5 mg/d or less.
Conclusion This trial demonstrates a trend to efficacy of dapsone as a steroid-sparing drug in maintenance-phase PV.
Trial Registration clinicaltrials.gov Identifier: NCT00429533
- A review of the NHS in England (‘Our NHS, Our Future’), conducted by Lord Ara Darzi, is due to be published in June 2008. The review will focus on access, quality and safety. In the run-up to the launch of the review, the King’s Fund will be carrying out various activities to inform the debate. They will publish research and debate the most pressing themes in the review and highlights from these debates will be made available on the King’s Fund website. Visitors to the site will have the opportunity to leave their comments. Further information is available via the link above.